首页> 外国专利> compound, composition, pharmaceutical composition, method for inducing degradation of a target protein in a cell and in a patient, method for treating a disease state or condition in a patient, compound identification method, compound library, and, cereblon-e3 ubiquitin ligase binding fraction

compound, composition, pharmaceutical composition, method for inducing degradation of a target protein in a cell and in a patient, method for treating a disease state or condition in a patient, compound identification method, compound library, and, cereblon-e3 ubiquitin ligase binding fraction

机译:化合物,组合物,药物组合物,在细胞和患者中诱导靶蛋白降解的方法,在患者中治疗疾病状态或病症的方法,化合物鉴定方法,化合物库和cereblon-e3泛素连接酶结合分数

摘要

The description relates to imide-based compounds, including bifunctional compounds comprising them, which find utility as modulators of targeted ubiquitination, especially inhibitors of a variety of polypeptides and other proteins that are degraded and / or otherwise. inhibited by the bifunctional compounds according to the present invention. In particular, the description provides compounds which contain, at one end, a ligand that binds to cereblon-e3 ubiquitin ligase and, at the other end, a moiety that binds to a target protein, such that the target protein is placed in close proximity. ubiquitin ligase to effect degradation (and inhibition) of this protein. Compounds that exhibit a wide range of pharmacological activities consistent with the degradation / inhibition of targeted polypeptides of almost any type may be synthesized.
机译:该描述涉及基于酰亚胺的化合物,包括包含它们的双官能化合物,其可用作靶向泛素化的调节剂,尤其是多种多肽和其他蛋白质的抑制剂和/或其他被降解的抑制剂。被本发明的双官能化合物抑制。特别地,该描述提供了这样的化合物,该化合物的一端包含与脑-e3泛素连接酶结合的配体,而另一端包含与靶蛋白结合的部分,从而使靶蛋白紧密相邻。泛素连接酶影响该蛋白的降解(和抑制)。可以合成具有与几乎任何类型的靶向多肽的降解/抑制一致的广泛药理活性的化合物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号